Active Ingredient(s):Ganaxolone FDA Approved: * March 18, 2022 Pharm Company: *MARINUS PHARAMCEUTICALS, INC Category:Anticonvulsant
Ganaxolone, sold under the brand name Ztalmy, is a medication used to treat seizures in people with cyclin-dependent kinase-like 5 (CDKL5) deficiency disorder (CDD).
Ganaxolone was approved for medical use in the United States in March 2022.
1.1 Mechanism of action
3.1 Clinical trials
5 External links
Mechanism of action
The exact mechanism of actio...
* May have multiple approval dates, manufacturers, or labelers.